Andrew Sim, MD
Pain Medicine · Fair Lawn, NJNPI 1912295122
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 142 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Nevro Corp. at 28.9% of the total. Reporting peaked in 2019 at $1,541 and has fallen 65.1% since, to $538 in 2025.
Across 142 payments — averaging $35.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$1K
- Boston Scientific$914
- Abbott$767
- Medtronic$398
- Stryker$334
- Nalu Medical, Inc.$252
- plus $969 from 16 others
What the payments were for
- Food & beverage$5,086100%
- Education$210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 22 | $1,474 |
| Boston Scientific | 26 | $914 |
| Abbott | 33 | $767 |
| Medtronic(2 entities) | 8 | $398 |
| Stryker | 2 | $334 |
| Nalu Medical, Inc. | 6 | $252 |
| Biotronik NRO, Inc. | 2 | $205 |
| DJO, LLC | 2 | $134 |
| Scilex Pharmaceuticals Inc. | 6 | $82 |
| Pfizer | 6 | $80 |
| Vertos Medical, Inc. | 2 | $64 |
| Novartis | 5 | $64 |
| Amgen | 4 | $61 |
| Teva Pharmaceuticals USA, Inc. | 4 | $59 |
| Lilly USA, LLC | 4 | $56 |
| Si-bone, Inc. | 2 | $40 |
| Hikma Pharmaceuticals USA | 2 | $35 |
| Bioventus LLC | 1 | $27 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $22 |
| SPR Therapeutics, Inc | 1 | $14 |
| Pacira Therapeutics, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,107 in reported general payments places this provider in the 75th percentile of 256 pain medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 43 | $904 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 53 | $790 |
| Celecoxib | 14 | $433 |
| Nabumetone | 34 | $314 |
| Meloxicam | 76 | $228 |
| Tizanidine Hcl | 21 | $195 |
| Pregabalin | 21 | $191 |
| Oxycodone Hcl | 13 | $160 |
| Cyclobenzaprine Hcl | 21 | $88 |
| Tramadol Hcl | 29 | $84 |
| Methylprednisolone | 12 | $55 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Fair Lawn
- Shaigan IqbalFair Lawn$6K
- Sean LiShrewsbury$1.2M
- Matthias WiederholzLawrenceville$853K
- Todd StitikNewark$370K
- Peter StaatsShrewsbury$286K
- Warren GraceEdison$158K
- Caitlin InnerfieldHaddonfield$97K
- Anson MoiseEnglewood$78K
- Pavli DemianSomerset$65K
- Dipan PatelClifton$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.